| Followers | 19 |
| Posts | 6173 |
| Boards Moderated | 0 |
| Alias Born | 01/04/2012 |
Friday, October 25, 2024 11:58:00 AM
Roddy4, it is hard to say exactly when. I estimate that they had a PDUFA date which the FDA could not meet, due to the massive amount of data to be reviewed. So we are just waiting for them to complete the review. Sometime the FDA automatically extends the PDUFA to give them additional time to complete a review. Since the NDA submission was between July 1, 2023 and September 30, 2023, we could see a decision soon. If approved, I expect a major announcement to be made prior to the approval being added to the FDA website. Since ANIP has not provided the PDUFA date, it is impossible to estimate exactly when we should hear.
Recent ANIP News
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity • GlobeNewswire Inc. • 04/20/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:40:36 PM
- ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules • IH Market News • 04/13/2026 03:12:39 PM
- ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules • GlobeNewswire Inc. • 04/13/2026 10:50:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:14:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:13:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:12:05 PM
- ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet • GlobeNewswire Inc. • 04/08/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:21:22 PM
- ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology • GlobeNewswire Inc. • 04/07/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:09:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:09:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:07:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:06:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:04:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:46:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 10:22:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:46:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:45:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:01:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 12:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:59:46 PM
